Parkinson's disease: clinical and therapeutic aspects

Abstract

Recent developments on the clinical and therapeutic aspects of idiopathic Parkinson's disease (IPD) have focused on the role of monoamine oxidase B inhibition in IPD, strategies to manage the long-term levodopa (L-dopa) syndrome and attempts to replace nigral tissue by grafting. In addition, tools for community screening and possible identification of an 'at-risk' as well as presymptomatic population of sufferers have been suggested.